👨⚕️#Nephrologist M.D. Head of @parisTxgroup. PhD #1 in Cell Biology 🧫 PhD #2 in Biostatistics 📊. Passionate about improving #Patient Care by #innovation
France
Joined July 2013
- Tweets2.3K
- Following6.3K
- Followers5.9K
- Likes7.3K
Alexandre Loupy retweeted
A new study identifies 7 distinct FEV1 trajectories post #LungTransplantation, each telling a different story of survival- should we consider personalized, trajectory-based monitoring of lung recipients? 🫁 @Raynaud_Maths, @drAntoineRoux, @AlexandreLoupy
🔗: jhltonline.org/article/S1053…
Alexandre Loupy retweeted
CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary: nej.md/4jEVbbk
ALT The New England Journal of Medicine Finerenone with Empagliflozin in CKD and Type 2 Diabetes A Research Summary based on Agarwal R et al. | 10.1056/NEJMoa2410659 | Published on June 5, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
Alexandre Loupy retweeted
📢 Just out in @NatureComms & presented @ESOTtransplant !
Our study "Impact of HLA evolutionary divergence and molecular mismatches on AMR of kidney allografts" is now published.
🔗nature.com/articles/s41467-0…
🙌to @zpdemir2
Carmen Lefaucheur @AlexandreLoupy
🔬 A look at the top-tier journals in medicine and biomedical science interesting! congratulation on these top tier journals🚀🦾🚀🤩
•The Lancet IF: 98.4
•NEJM IF: 96.2
•The BMJ IF: 93.6
•Nature Medicine IF: 50.0
•JAMA IF: 50.0
•Nature IF: 48.5
From @ESOTtransplant #esotcongress 2025 2 amazing days working with colleagues on the @TheLancet commission. Paving the future of organ transplantation in the next 15 years !!!
Great thing about having the Lancet commission meeting ahead of #ESOT2025 is that you can see an empty congress space quiet before the storm ! looking forward to meeting with colleagues and friends and share science !! @gabriel_oniscu
Alexandre Loupy retweeted
📢 New publication in Xenotransplantation Journal by our group @ParisTxGroup @AlexandreLoupy !
Among the 2,900+ Xeno papers we assessed, 706 focused on solid organ & islet transplants from animals to humans 🐷➡️🧍
lnkd.in/eVKHzNVn
Here’s a summary of what we found 👇
Alexandre Loupy retweeted
Beyond standard of care monitoring for patients who are post-transplant, urinary chemokine CXCL9 demonstrated limited clinical utility, while CXCL10 provided no additional value. kidney.pub/JASN0742 #ASNJASN
Direct from Choose Europe 🇪🇺for Science: A Bold Step from Paris 🇫🇷 !
Transplant researchers: if you’re ready to innovate, 🇫🇷 might be your next destination🛬.
@ParisTxGroup is ready 🚀🤖🦾#PITOR #FranceForScience DM me if interested
Thank you 🙏 for an amazing event and so many bright people ! go Mayo !
@MayoClinicNeph , Hypertension and Kidney Transplantation Update for the Clinician 2025 from Kidney stones to AI in Tx fantastic presentations @AlexandreLoupy @keddis_mira @lieske_john
Proud of my team @ParisTxGroup and the amazing work done for @ESOTtransplant abstract submission! We are proud of the research submitted in kidney - Heart - Lung - Liver and Xeno ! addressing key challenges and encompassing large trials and cutting edge technologies. @gabriel_oniscu @Olivier_Thaunat
Alexandre Loupy retweeted
Interested in our team’s @NEJM publication on microvascular inflammation in kidney allografts and its clinical outcomes? Check out the coverage in @pathologistmag, highlighting the key findings and the study’s impact.
thepathologist.com/subspecia…
Another great milestone in Xenotransplantation
Congratulations to the amazing @nyulangone team !
nyulangone.org/news/gene-edi…
Alexandre Loupy retweeted
We recently announced a collection of 40+ peer-reviewed papers in @NaturePortfolio marking a significant progress in our understanding of the human body and providing a foundation from which the first version of atlas will be assembled.
nature.com/collections/jccbb…
I had the privilege of being invited to give a lecture @karolinskainst 🇸🇪 Truly honored and inspired to stand so close to the building where the The Nobel Prize are being awarded this week.
A special shoutout to @Gabriel Oniscu @ESOTtransplant for his exceptional leadership.
Alexandre Loupy retweeted
📖 This weekend don't miss our @Kidney_Int #ISNFridaySelection: Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN) kidney-international.org/art…
